Paige Collins: Thank You To OncoDaily For An Excellent Sarcoma Grand Rounds Discussion

Fran Brophy on OncoDaily Grand Rounds at ASCO 2026: Sarcoma Edition

Christopher Clinton Conway: Presenting The OncoDaily Natera 2026 Yvonne Award At ASCO

Oncology News, Insights, Stories by OncoDaily

Yvonne Awards
OncoDaily Pulse

Yvonne Awards 2026 Honored Leaders Shaping the Future of Oncology

OncoDaily Grand Rounds
OncoDaily Pulse

OncoDaily Grand Rounds at ASCO 2026: Sarcoma Edition Brought Global Experts Together in Chicago

Grand Rounds by OncoDaily: AI in Oncology Edition
OncoDaily

Grand Rounds by OncoDaily: AI in Oncology Edition

Caroline Chung: Thank You OncoDaily for the Recognition Through Yvonne Award for AI Oncology

Ruiling Yuan Celebrates Colleague Dr. Joanna Metzner-Sadurski's Yvonne Award Triumph

Amol Akhade: Honored to Receive the Voice of Oncology Award from OncoDaily

SUCCESSOR-2: Improved PFS and Response Rates With Mezigdomide + Kd vs Kd in R/R Multiple Myeloma

EV-302 at ASCO 2026: 3.5-Year Follow-Up Confirms Long-Term Benefit of EV Plus Pembro in la/mUC

MajesTEC-9 Results at ASCO 2026: Teclistamab Monotherapy Demonstrates Superiority Over PVd/Kd in Earlier-Line RRMM

AMBASSADOR at ASCO 2026: HRQOL with Pembrolizumab or observation After Surgery in High-Risk MIUC

Voices
Chinmay Jani

Chinmay Jani: Always Great Catching up With Narjust Florez

Sarah Sammons: ALND Indications in 2026 per Boughey at ASCO 2026

Kevin Lu: Top Poster Recognition for Work on Uncommon EGFR Mutations at ASCO

Tom Powles: Talazoparib + Enzalutamide Delivers Strong Results in mCSPC

Bishal Gyawali: One of the Most Humane Sessions at ASCO26

ASCO26 GU Highlights by Fuat Bicer

Elizabeth Nally: Thank You Sumanta K. Pal. It Was a Privilege to Present These Analyses From IMmotion010

FDA Approvals
Decnupaz

FDA Approves Decnupaz (pivekimab sunirine-pvzy), the First ADC for Adults With BPDCN

FDA Approves FoundationOne CDx as Companion Diagnostic for TEPMETKO in METex14 NSCLC

FDA approved Atezolizumab for adjuvant treatment of MDR–positive MIBC

FDA Grants Approval for Oral Decitabine/Cedazuridine With Venetoclax in Newly Diagnosed AML

FDA Greenlit New Pancreatic Cancer Drug Daraxonrasib For Expanded Access

FDA Grants Full Approval of Tecartus for Relapsed/Refractory Mantle Cell Lymphoma in Adults

FDA Grants Fast Track Designation to TRI-611 in ALK-Positive NSCLC

OncoDaily 100
100 Xfluencers in Prostate Cancer

100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2025

The 100 Most Influential CEOs in Oncology in 2025 (Full List)

The 100 Most Influential People in Oncology in 2025 (Full List)

100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2025

100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2024

Top 100 Xfluencers in Lung Cancer: Key Opinion Leaders to Follow on X (Twitter) in 2024

Top 100 Xfluencers in Breast Cancer: Key Opinion Leaders to Follow on X (Twitter) in 2024

Celebrities and Cancer

OncoCalendar

BTOG (British Thoracic Oncology Group) National Trials Meeting 2026

British Thoracic Oncology Group

22 Jul
British Thoracic Oncology Group

SPCC (Sharing Progress in Cancer Care) Webinar - HER2DX: Translating Biology into Care

Sharing Progress in Cancer Care

16 Jun
SPCC

MASCC Webinar: The Role of Biosimilars in Expanding Access and Sustainability

MASCC

11 Jun
MASCC

ASCO 2026: Key Highlights for Stomach/Gastric Cancer Patients

GI Cancers Alliance

09 Jun
ASCO 2026: Key Highlights for Stomach/Gastric Cancer Patients

2nd International Conference on Cancer Research and Immuno-Oncology

Researchers Fusion

30 May
Immuno-Oncology

Immune-oncology
IMA401-101 Study: First-in-Human TCER IMA401 in Advanced Solid Tumors

IMA401-101 Study: First-in-Human TCER IMA401 in Advanced Solid Tumors

A-BRAVE Trial: Time-of-Day Administration of Immunotherapy in Triple-Negative Breast Cancer

HELEN-Trio 011 Trial: Camrelizumab Plus Anthracycline-Free Neoadjuvant Therapy in TNBC

EMITT-1 Study: GRWD5769 Plus Cemiplimab in Anti–PD-1–Resistant Solid Tumors and MSS Colorectal Cancer

KEYNOTE-522 Final Analysis: Pembrolizumab Plus Chemotherapy in High-Risk Early-Stage TNBC

PD-(L)1 Rechallenge After Immunotherapy Resistance in Advanced NSCLC

DELII trial: Ultra-Low-Dose Immunotherapy in Relapsed Refractory Solid Tumors

Gastrointestinal-Oncology
CHALLENGE at ASCO 2026

CHALLENGE at ASCO 2026: Cost-Utility Analysis of Exercise After Adjuvant Chemotherapy in Colon Cancer

EPISODE-III at ASCO 2026: Adjuvant Aspirin in Stage III Colorectal Cancer After Curative Resection

BREAKWATER at ASCO 2026: Encorafenib plus Cetuximab and FOLFIRI in BRAF V600E-Mutant mCRC

CIRCULATE at ASCO 2026: ctDNA-Guided Adjuvant Treatment Improved TTR and DFS in Stage II Colon Cancer

HERIZON-GEA-01 Updates: Zanidatamab ± Tislelizumab in HER2-Positive Gastroesophageal Cancer

Phase 3 LAPIS Trial: Pamrevlumab Plus Chemotherapy in Locally Advanced Pancreatic Cancer

10 Must-Read Posts In GI Oncology This Week

Breast-Oncology
SENOMAC

SENOMAC: Omitting Completion Axillary Dissection Maintains Survival and Reduces Arm Morbidity in Breast Cancer

OPTIMA: Prosigna-Guided Chemotherapy Avoidance Shows Non-Inferior Outcomes in ER+/HER2− Early Breast Cancer

WSG TP-II Trial: Excellent 5-Year Survival After De-Escalated Neoadjuvant Therapy In HR+/HER2+ Early Breast Cancer

HER2-Positive Breast Cancer: From Fear to a Story of Hope

Dato-DXd Plus Durvalumab Shows Durable First-Line Activity in Advanced TNBC

NeoTRIPaPDL1 Transcriptomic Analysis Reveals Early Predictors of Response in TNBC

TQB2102 Shows Early Activity Across HER2-Expressing Solid Tumors

Lung-Oncology
Triton

TRITON Interim Analysis: Tremelimumab Plus Durvalumab And Chemotherapy Shows Early Response Signal In STK11/KEAP1/KRAS-Mutated NSCLC

AcceleRET-Lung: Pralsetinib Improves First-Line PFS In RET Fusion–Positive Advanced NSCLC

OptiTROP-Lung05: Sac-TMT Plus Pembrolizumab Improves PFS in PD-L1–Positive Advanced NSCLC

ASCO 2026: Sunvozertinib Versus Chemotherapy in First-Line EGFR exon20ins Advanced NSCLC

Proton Therapy vs IMRT in Locally Advanced NSCLC: Long-Term Results Show Similar Lung Toxicity, With A Cardiac Signal Favoring Proton Therapy

DESTINY-Lung03: T-DXd Confirms Activity in HER2-Overexpressing NSCLC, but Triplet Therapy Falls Short

Henlius Advances HLX43 Phase 2 Trial in NSCLC With First EU Patient Dosed

OncoDaily TV
OncoDaily Grand Rounds at ASCO 2026: Sarcoma Edition: Highlights of the event

OncoDaily Grand Rounds at ASCO 2026: Sarcoma Edition: Highlights of the event

How Desmond Yip Helped Build Cancer Care in the Solomon Islands

How Desmond Yip Helped Build Cancer Care in the Solomon Islands

Gynecological Cancers, Cancer Vaccines & Immunotherapy: Are We Near Elimination?

Gynecological Cancers, Cancer Vaccines & Immunotherapy: Are We Near Elimination?

Annalice Gandini

GI News Updates with Annalice Gandini

Ringing the Bell Is Not the End of the Story, but the Beginning of a New One: Alejandra Méndez

Ringing the Bell Is Not the End of the Story, but the Beginning of a New One: Alejandra Méndez

Episode 15: Global Health Dialogues with Princess Dina and Dr Garo Armen

Episode 15: Global Health Dialogues with Princess Dina and Dr Garo Armen

Hisham Mehanna

What It Takes to Lead in Oncology Prof. Hisham Mehanna on Research, Mentorship & Life Balance

ASCO

ASCO 2026 with OncoDaily: Yvonne Awards, AI in Oncology, Grand Rounds and Live Coverage from Chicago

Lucica Ditiu

Ending Tuberculosis by 2030: Is It Still Possible? | Dr Lucica Ditiu

City-Level Cancer Care: A Missing Piece in the Puzzle?

City-Level Cancer Care: A Missing Piece in the Puzzle?

Empowering Oncologists: Why Survivorship Matters?

Empowering Oncologists: Why Survivorship Matters?

Professor Richard Sullivan: Building Cancer Systems Amidst Global Instability

Professor Richard Sullivan: Building Cancer Systems Amidst Global Instability

Not To Miss
OncoDaily Sarcoma Grand Rounds

OncoDaily Sarcoma Grand Rounds Highlights

22 Posts Not To Miss From ASCO 2026 Day 1

20 Posts Not To Miss From IARC60 Conference

25 Posts Not To Miss From WHA79

Highlights From How I Treat Bladder Cancer in 2026: OncoDaily Virtual Summit

20 Posts Not To Miss From AUA26: American Urological Association Annual Meeting

King Hussein Cancer Research Award: Advancing Cancer Research Across the Arab World 2026

OncoGrants
Global Ovarian Cancer Research Consortium AI Accelerator Grant — OCRA

Global Ovarian Cancer Research Consortium AI Accelerator Grant — OCRA

ACOG Foundation 2026 Request for Grant Proposals

ACOG Foundation 2026 Request for Grant Proposals

Clinical Trial Award — DoD OCRP

Clinical Trial Award — DoD OCRP

Ovarian Cancer Academy – Early-Career Investigator Award — DoD OCRP

Ovarian Cancer Academy – Early-Career Investigator Award — DoD OCRP

Investigator-Initiated Research Award — DoD Ovarian Cancer Research Program

Investigator-Initiated Research Award — DoD Ovarian Cancer Research Program

Kids Beating Cancer — John Voight Memorial Leukemia Research Grant

Kids Beating Cancer — John Voight Memorial Leukemia Research Grant

Oncologist near me
Oncologist Near Me

Oncologist Near Me – Gregory Kalemkerian: Advancing Lung Cancer Care, Research, and Education
Oncologist Near Me

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership
Oncologist Near Me

Oncologist Near Me – Paolo Tarantino: Shaping the Future of Breast Cancer Treatment
Oncologist Near Me

Oncologist Near Me – Rana McKay: A Rising Force in Genitourinary Cancer Research and Care
Oncologist Near Me

Oncologist Near Me – Razelle Kurzrock: Revolutionizing Cancer Treatment Through Precision Medicine
Oncologist Near Me

Oncologist Near Me – Yelena Janjigian: A Global Leader in Gastrointestinal Oncology
Oncologist Near Me

Oncologist Near Me – Bishal Gyawali: Challenging the Status Quo in Global Oncology
Oncologist Near Me

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology
Oncologist Near Me

Oncologist Near Me – Wafik S. El-Deiry: A Global Leader in Translational Oncology and Cancer Research
Oncologist Near Me

Oncologist Near Me – Enrique Soto: A Leader in Geriatric Oncology and Global Cancer Care

Cancer types
CLL-RT

Richter Transformation (RT): When Chronic Lymphocytic Leukemia Turns Aggressive

Acute Myeloid Leukemia (AML) in 2026: The Current Landscape and Future Perspectives

Follicular Lymphoma (FL): From Evolving Biology to Modern Therapeutic Paradigms

Hodgkin Lymphoma (HL): Microenvironmental Biology Behind a Therapeutic Success Story

Colorectal Cancer: Epidemiology, Pathogenesis, Diagnosis, and Therapeutic Advances

Cholangiocarcinoma: Latest Risk Factors, Symptoms, Diagnosis, and 2025 Advanced Treatment Options for Bile Duct Cancer

Pheochromocytoma: Causes, Diagnosis, Treatment, and Breakthrough 2025 Advances in Management

CancerWorld

Oncologists
Joshua Brody

Joshua Brody

Oncologists Location New York, USA
Abeid Athman Omar

Abeid Athman Omar

Oncologists Location Nairobi, Kenya
Ninad Katdare

Ninad Katdare

Oncologists Location Mumbai, India
Jean-Yves Blay

Jean-Yves Blay

Oncologists Location Lyon, France
Juliet Lumati

Juliet Lumati

Oncologists Location Illinois, USA
Olubukola Ayodele

Olubukola Ayodele

Oncologists Location Leicester, United Kingdom
Mohamed Emam Sobeih

Mohamed Emam Sobeih

Oncologists Location Giza, Egypt
Luciano Mutti

Luciano Mutti

Oncologists Location L’Aquila, Italy

Oncology Drugs
Sacituzumab Tirumotecan

Sacituzumab Tirumotecan: What Patients Should Know About This Emerging Cancer Treatment

Sacituzumab Tirumotecan: Clinical Development, Mechanism, and Emerging Role in Modern Oncology

Lurbinectedin: What Patients Should Know

Lurbinectedin in Oncology: Mechanism, Clinical Data, Evolving Role, and Future Directions

Bemarituzumab: What Patients with Gastric Cancer Should Know

Bemarituzumab: Uses in Cancer, Side Effects, Dosages, Expectations and More

GSK5764227 (HS-20093): A Novel B7-H3 Targeted Antibody–Drug Conjugate Under Clinical Investigation

OncoDaily Magazine

New Paper Alert
Cardiovascular Disease

Prevention And Management Of Cardiovascular Disease In Adults With Cancer: IC-OS And MASCC Clinical Practice Statement

EORTC–ESTRO

Endpoints in Metastases Directed Therapy for Oligometastatic Cancer A Review and Consensus by the EORTC–ESTRO OligoCare Consortium

MONTBLANC Trial

MONTBLANC Trial Recruitment Completed: Triple Immunotherapy in Advanced HCC

Clinical Trial

How Clinicians Can Truly Understand Clinical Trial Results?

OrigAMI-1 Trial

OrigAMI-1 Trial: Amivantamab in Refractory Metastatic Colorectal Cancer

Drug Discovery

Human-Centric New Approach Methodologies in Drug Discovery

OncoDaily Medical Journal

Hematology

10.69690/ODMJ-001-0526-7344

Analysis of Mortality Factors in the Pediatric Hemato-Oncology Department of the Children's Hospital of Rabat, 2022-2023
Original Research

Radiation Oncology

10.69690/ODMJ-011-0526-7409

An Independent Read-Only Verification and Risk-Management System to Maintain Radiotherapy Safety During Oncology Information System Failure
Case Reports/Brief Reports

Cancer Care

10.69690/ODMJ-001-0426-7451

Distinct differences in the tumour-resident microbiome between early- and late-onset colorectal cancer
Original Research

Hematology

10.69690/odmj-012-0426-7512

Frailty, infections, and bispecific antibodies in multiple myeloma: redefining supportive care in the era of T-cell redirection
Commentaries

Oncology Nursing

10.69690/ODMJ-002-0426-7359

Barriers and Facilitators of Oral Nutritional Supplement Adherence in Cancer: A Systematic Review
Review

Hematology

10.69690/ODMJ-011-0426-7452

Double Dilemma: Managing a Sequential Lymphoma (Case Report)
Case Reports/Brief Reports

Hematology

10.69690/ODMJ-011-0426-7442

Outcome of Hematopoietic Stem Cell Transplantation in Pediatric Patients with Severe Aplastic Anemia and Multi-Drug Resistant Bacterial Infections - A Case Series
Case Reports/Brief Reports

Oncology Nursing

10.69690/ODMJ-001-0404-7332

Enhancing Palliative Care Through Simulation-Based Workshops for Effective Symptom Management
Original Research